Regulating Alcohol: Strategies Used by Actors to Influence COVID-19 Related Alcohol Bans in South Africa.

COVID-19 alcohol regulation government industry prohibition

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
31 10 2021
Historique:
received: 01 10 2021
revised: 28 10 2021
accepted: 28 10 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 19 11 2021
Statut: epublish

Résumé

South Africa has used intermittent alcohol prohibitions and restrictions as a strategy to relieve hospitals of alcohol-related trauma cases and spare services for COVID-19 caseloads. Alcohol regulation is highly contested and involves a diverse range of actors who influence policies to align with their interests. This study sought to examine the strategies used by these actors to shape the COVID-19 related alcohol regulation in South Africa as presented by online news media. We found that the voice of pro-regulation actors is smaller and fragmented compared to opponents of the regulation as each actor seeks to advance their own interests. Despite the regulations initially being framed as a COVID-19 public health measure, pro-regulation government ministries, such as police and transport, perceive the regulations as a way of reducing existing (pre-pandemic) alcohol-related harm, such as crime, road-traffic injuries, and gender-based violence. The pre-existing failures in the alcohol regulatory environment and the current policy momentum created by COVID-19 could present an opportunity to retain components of the new laws and improve alcohol regulation in South Africa. However, there is a dominant and cohesive alcohol industry voice that strongly opposes the regulations, citing economic impacts, illicit trade and lack of evidence on the positive effects of the alcohol bans. Strategies employed by industry include lobbying, framing, and litigation. The regulations implemented under the guise of COVID-19 prevention have presented valuable lessons for alcohol regulation more generally. However, whether these regulations translate to sustainable policy changes will depend upon how and if the strong industry voice is countered.

Identifiants

pubmed: 34770009
pii: ijerph182111494
doi: 10.3390/ijerph182111494
pmc: PMC8582952
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Health Commun. 2014;29(5):431-44
pubmed: 23829316
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Lancet. 2009 Jun 27;373(9682):2247-57
pubmed: 19560606
Health Policy Plan. 2018 Sep 1;33(7):786-800
pubmed: 29931204
Health Policy Plan. 2021 Aug 09;:
pubmed: 34369574
S Afr Med J. 2020 Dec 14;111(2):110-113
pubmed: 33944719
Int J Health Policy Manag. 2020 Nov 01;9(11):486-487
pubmed: 32610805
Drug Alcohol Rev. 2021 Sep 22;:
pubmed: 34551171
Addiction. 2016 Jan;111(1):18-32
pubmed: 26173765
BMC Med. 2018 Jun 25;16(1):97
pubmed: 29936909
JAMA Surg. 2014 Jun;149(6):549-56
pubmed: 24789507
Lancet. 2014 Jun 7;383(9933):1972
pubmed: 24910230
Afr J Emerg Med. 2019;9(Suppl):S14-S20
pubmed: 31073509
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Addiction. 2010 Aug;105(8):1340-5
pubmed: 20653617
BMJ Glob Health. 2020 Apr 16;5(4):e001958
pubmed: 32377401
J Public Health Policy. 1996;17(3):306-30
pubmed: 8918021
Health Promot Int. 2017 Aug 1;32(4):755-761
pubmed: 26747659
S Afr Med J. 2007 Aug;97(8 Pt 2):664-72
pubmed: 17952223
Drug Alcohol Rev. 2021 May 17;:
pubmed: 33998731
J Public Health Manag Pract. 2018 Jan/Feb;24(1):4-8
pubmed: 28257409
Int J Health Policy Manag. 2019 May 19;8(7):450-454
pubmed: 31441282
J Health Polit Policy Law. 2013 Oct;38(5):987-1021
pubmed: 23794743
Tob Control. 2014 May;23(e1):e35-43
pubmed: 24614041
Health Place. 2016 May;39:204-11
pubmed: 27132687
Alcohol Alcohol. 2011 Mar-Apr;46(2):200-3
pubmed: 21273300
Tob Induc Dis. 2020 May 06;18:39
pubmed: 32395100
Lancet. 2007 Oct 13;370(9595):1370-9
pubmed: 17933652

Auteurs

Yandisa Ngqangashe (Y)

School of Regulation and Global Governance, The Australian National University, 8 Fellows Road, Canberra, ACT 2601, Australia.
ANU College of Asia and the Pacific, The Australian National University, 8 Fellows Road, Canberra, ACT 2601, Australia.

Maddie Heenan (M)

The Australian Prevention Partnership Centre, The Sax Institute, Glebe, NSW 2037, Australia.
The George Institute for Global Health, Level 5/1 King St., Newtown, NSW 2042, Australia.

Melanie Pescud (M)

School of Regulation and Global Governance, The Australian National University, 8 Fellows Road, Canberra, ACT 2601, Australia.
ANU College of Asia and the Pacific, The Australian National University, 8 Fellows Road, Canberra, ACT 2601, Australia.
The Australian Prevention Partnership Centre, The Sax Institute, Glebe, NSW 2037, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH